![Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors (Contemporary Endocrinology) [Repost]](https://pixhost.icu/avaxhome/f7/0b/00470bf7_medium.jpg)
Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors (Contemporary Endocrinology) [Repost]
![Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors (Contemporary Endocrinology) [Repost]](https://pixhost.icu/avaxhome/f7/0b/00470bf7.jpg)
Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors (Contemporary Endocrinology) by Karel Pacak
English | 15 Jan. 2017 | ISBN: 3319460366 | 500 Pages | PDF | 14.13 MB
English | 15 Jan. 2017 | ISBN: 3319460366 | 500 Pages | PDF | 14.13 MB
Based on the most novel approaches and cutting-edge clinical and scientific information regarding radionuclide imaging and therapies for neuroendocrine tumors, this clinical guidebook represents a unique collaborative effort between endocrinologists, nuclear physicians, oncologists, surgeons, physicists, radio-pharmacists and geneticists. It begins with the embryology, classification and molecular genetics of gastroenteropancreatic neuroendocrine tumors and carcinoids, chromaffin cell tumors, and MEN1- and MEN2-related tumors. Following a chapter on radiopharmaceuticals in neuroendocrine imaging, it turns to the physics and technology of current and cutting-edge radiology, including SPECT/CT and PET/CT and PET/MR. Discussing of radionuclide imaging covers the tumors mentioned above, as well as pulmonary and thymic neuroendocrine tumors and medullary thyroid carcinoma. A presentation of radionuclide therapies follows, including 131I-MIBG therapy, somatostatin receptor-based therapy, and alpha radionuclide therapy, as well as the role of nanoparticles.